Results
Twenty-nine patients had a supervised, automated Dora call as part of
their care following informed consent. Age ranged from 22 - 83 years,
(mean 47 years), with 19 female and 10 male patients. 100% (n=29) of
the calls were successfully completed, and 100% (n=29) of the symptoms
were satisfactorily labelled by the supervising clinician from Dora’s
automated conversation. Dora was able to independently capture and label
95% of all the symptoms (Range 83%-100%). Of the 406 symptom labels,
agreement levels between Dora and the clinical supervisor were on
average 89% (range 79-100%) (Figure 1). 66% (n=19) were classified as
‘high’ risk of having HNC (>7.1%), with 34% (n=10)
classified as low risk of having HNC (<7.0%). None of the
patients were ultimately diagnosed with HNC (confirmed at 1 year).
Patient acceptability was high, net promoter scores ranged from 4 to 10,
with a median NPS of 8 out of 10, and a calculated NPS of 56% (Figure
2).